Shenzhen Colibri Technologies Co.Ltd(002957) said on the interactive platform that the company’s current operation is in good condition. Focusing on the “3 + n” business strategic layout, the business mainly focuses on the mobile terminal industry and new energy industry. In the field of medical and health care, the company’s main products are in vitro diagnostic reagent (IVD) automatic filling line equipment, which currently accounts for a small proportion of the company’s overall income. The company will make certain technical reserves and make plans in the future in combination with the changes of market demand.
© China Stock Market News